Clinical aspects of hyperthyroidism, hypothyroidism, and thyroid screening in pregnancy

Endocrine Practice

Volumn 20, Issue 6, 2014, Pages 597-607

  Negro, Roberto ^a   Stagnaro Green, Alex ^b  

^a VITO FAZZI HOSPITAL   (Italy)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; IODINE; THYROID ANTIBODY; THYROTROPIN;

ADVERSE OUTCOME; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNITY; DISEASE ASSOCIATION; FERTILIZATION IN VITRO; FETUS WASTAGE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INTELLIGENCE QUOTIENT; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFERENCE VALUE; SCREENING TEST; SPONTANEOUS ABORTION; SUBCLINICAL HYPOTHYROIDISM; SYSTEMATIC REVIEW; THIRD TRIMESTER PREGNANCY; THYROID DISEASE; THYROID FUNCTION; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; FEMALE; IMMUNOLOGY; PREGNANCY COMPLICATIONS; THYROID GLAND;

AUTOIMMUNITY; FEMALE; FERTILIZATION IN VITRO; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; PREGNANCY; PREGNANCY COMPLICATIONS; THYROID GLAND;

EID: 84903575751     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP13350.RA     Document Type: Article

References (83)

1. Glinoer D. The regulation of thyroid function in pregnancy: Pathways of endocrine adaptation from physiology to pathology. Endocr Rev. 1997.;18:404Y433
2. Haddow J, McClain M, Lambert-Messerlian G, et al. Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy. J Clin Endocrinol Metab. 2008.;93:3341Y3347
3. Dashe JS, Casey BM, Wells CE, et al. Thyroid-stimulating hormone in singleton and twin pregnancy: Importance of gestational age-specific reference ranges. Obstet Gynecol. 2005.;106:753Y757
4. Soldin OP. Thyroid function testing in pregnancy and thyroid disease: Trimester-specific reference intervals. Ther Drug Monit. 2006.;28:8Y11
5. Haddow JE, Knight GJ, Palomaki GE, McClain MR, Pulkkinen AJ. The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy. J Med Screen. 2004.;11:170Y174
6. Stricker R, Echenard M, Eberhart R, et al. Evaluation of maternal thyroid function during pregnancy: The importance of using gestational age-specific reference intervals. Eur J Endocrinol. 2007.;157:509Y514
7. Panesar NS, Li CY, Rogers MS. Reference intervals for thyroid hormones in pregnant Chinese women. Ann Clin Biochem. 2001.;38:329Y332
8. Soldin OP, Soldin D, Sastoque M. Gestation-specific thyroxine and thyroid stimulating hormone levels in the United States and worldwide. Ther Drug Monit. 2007.;29:553Y559
9. Bocos-Terraz JP, Izquierdo-Alvarez S, Bancalero-Flores JL, et al. Thyroid hormones according to gestational age in pregnant Spanish women. BMC Res Notes. 2009.;2:237
10. Marwaha RK, Chopra S, Gopalakrishnan S, et al. Establishment of reference range for thyroid hormones in normal pregnant Indian women. BJOG. 2008.;115:602Y606
11. De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012.;97:2543Y2565
12. Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011.;21:1081Y1125
13. Goodwin TM, Montoro M, Mestman JH. Transient hyperthyroidism and hyperemesis gravidarum: Clinical aspects. Am J Obstet Gynecol. 1992.;167:648Y652
14. Lockwood CM, Grenache DG, Gronowski AM. Serum human chorionic gonadotropin concentrations greater than 400,000 IU/L are invariably associated with suppressed serum thyrotropin concentrations. Thyroid. 2009.;19: 863Y868
15. Verberg MF, Gillott DJ, Al-Fardan N, Grudzinskas JG. Hyperemesis gravidarum, a literature review. Hum Reprod Update. 2005.;11:527Y539
16. Montoro M, Spencer C, Jacobson S, et al. Evidence for a physiological role of hCG as a thyroid stimulator: Genesis of hyperthyroidism in hyperemesis gravidarum. Clin Res. 1984.;32:20A.
17. Goodwin TM, Montoro M, Mestman JH, Pekary AE, Hershman JM. The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab. 1992.;75:1333Y1337
18. Kauppila A, Huhtaniemi I, Ylikorkala O. Raised serum human chorionic gonadotrophin concentrations in hyperemesis gravidarum. BMJ. 1979.;1:1670Y1671
19. Casey BM, Dashe JS, Wells CE, et al. Subclinical hypothryoidism and pregnancy outcomes. Obstet Gynecol. 2005.;105:239Y245
20. Vaidya B, Anthony S, Bilous M, et al. Detection of thyroid dysfunction in early pregnancy: Universal screening or targeted high-risk case finding? J Clin Endocrinol Metab. 2007.;92:203Y207
21. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev. 2010.;31:702Y755
22. Mestman JH. Hyperthyroidism in pregnancy. Curr Opin Endocrinol Diabetes Obes. 2012.;19:394Y401
23. Smith C, Thomsett M, Choong C, Rodda C, McIntyre HD, Cotterill AM. Congenital thyrotoxicosis in premature infants. Clin Endocrinol (Oxf). 2001.;54:371Y376
24. Mitsuda N, Tamaki H, Amino N, Hosono T, Miyai K, Tanizawa O. Risk factors for developmental disorders in infants born to women with Graves disease. Obstet Gynecol. 1992.;80:359Y364
25. Wing DA, Millar LK, Koonings PP, Montoro MN, Mestman JH. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol. 1994.;170:90Y95
26. Momotani N, Noh JY, Ishikawa N, Ito K. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. J Clin Endocrinol Metab. 1997.;82:3633Y3636
27. Hackmon R, Blichowski M, Koren G. The safety of methimazole and propylthiouracil in pregnancy: A systemic review. J Obstet Gynaecol Can. 2012.;34:1077Y1086
28. Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol. 1994.;84:946Y949
29. Clementi M, Di Gianantonio E, Cassina M, Leoncini E, Botto LD, Mastroiacovo P. Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab. 2010.;95:E337-E341
30. Yoshihara A, Noh J, Yamaguchi T, et al. Treatment of Graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab. 2012.;97:2396Y2403
31. Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: Management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract. 2011.;17:456Y520
32. Cooper DS, Rivkees SA. Putting propylthiouracil in perspective. J Clin Endocrinol Metab. 2009.;94:1881Y1882
33. Rotondi M, Cappelli C, Pirali B, et al. The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy. J Clin Endocrinol Metab. 2008.;93:3985Y3988
34. Rotondi M, Pirali B, Lodigiani S, et al. The post partum period and the onset of Graves' disease: An overestimated risk factor. Eur J Endocrinol. 2008.;159:161Y165
35. Jansson R, Dahlberg PA, Winsa B, Meirik O, Säfwenberg J, Karlsson A. The post partum period constitutes an important risk for the development of clinical Graves' disease in young women. Acta Endocrinol (Copenh). 1987.;116:321Y325
36. Tada H, Hidaka Y, Tsuruta E, et al. Prevalence of postpartum onset of disease within patients with Graves' disease of child-bearing age. Endocr J. 1994.;41:325Y327
37. Benhaim Rochester D, Davies TF. Increased risk of Graves' disease after pregnancy. Thyroid. 2005.;11:1287Y1290
38. Shah MS, Davies TF, Stagnaro-Green A. The thyroid during pregnancy: A physiological and pathological stress test. Minerva Endocrinol. 2003.;28:233Y245
39. Stagnaro-Green A. Overt hyperthyroidism and hypothyroidism during pregnancy. Clin Obstet Gynecol. 2011.;54: 478Y487
40. Moreno-Reyes R, Glinoer D, Van Oyen H, Vandevijvere S. High prevalence of thyroid disorders in pregnant women in a mildly iodine-deficient country: A population-based study. J Clin Endocrinol Metab. 2013.;98:3694Y3701
41. Blatt A, Nakamoto JM, Kaufman HW. National status of testing for hypothyroidism during pregnancy and postpartum. J Clin Endocrinol Metab. 2012.;97:777Y784
42. Korevaar TI, Medici M, de Rijke YB, et al. Ethnic differences in maternal thyroid parameters during pregnancy: The Generation R study. J Clin Endocrinol Metab. 2013.;98: 3678Y3786
43. Sahu MT, Das V, Mittal S, Agarwal A, Sahu M. Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome. Arch Gynecol Obstet. 2010.;281:215Y220
44. Nelson DB, Casey BM, McIntire DD, Cunningham FG. Subsequent pregnancy outcomes in women previously diagnosed with subclinical hypothyroidism. Am J Perinatol. 2014.;31:77Y84
45. Benhadi N, Wiersinga WM, Reitsma JB, Vrijkotte TG, Bonsel GJ. Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol. 2009.;160:985Y991
46. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab. 2010.;95:E44-E48
47. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab. 2010.;95:1699Y1707
48. Lazarus JH, Bestwick JP, Channon S, et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med. 2012.;366:493Y501
49. Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med. 2004.;351: 241Y249
50. Yassa L, Marqusee E, Fawcett R, Alexander EK. Thyroid hormone early adjustment in pregnancy (the THERAPY) trial. J Clin Endocrinol Metab. 2010.;95:3234Y3241
51. Abalovich M, Alcaraz G, Kleiman-Rubinsztein J, et al. The relationship of preconception thyrotropin levels to requirements for increasing the levothyroxine dose during pregnancy in women with primary hypothyroidism. Thyroid. 2010.;20:1175Y1178
52. Galofré JC, Haber RS, Mitchell AA, Pessah R, Davies TF. Increased postpartum thyroxine replacement in Hashimoto's thyroiditis. Thyroid. 2010.;20:901Y908
53. Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Alvarez-Marfany M, Davies TF. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA. 1990.;264:1422Y1425
54. Iijima T, Tada H, Hidaka Y, Mitsuda N, Murata Y, Amino N. Effects of autoantibodies on the course of pregnancy and fetal growth. Obstet Gynecol. 1997.;90:364Y369
55. Ghafoor F, Mansoor M, Malik T, et al. Role of thyroid peroxidase antibodies in the outcome of pregnancy. J Coll Physicians Surg Pak. 2006.;16:468Y471
56. Sezer K, Kamel N, Unlu C, Celik HK. Impact of first trimester and postpartum period thyroid autoantibodies on abortus incidence in Turkish pregnant women. Gynecol Endocrinol. 2009.;25:387Y391
57. van den Boogaard E, Vissenberg R, Land JA, et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: A systematic review. Hum Reprod Update. 2011.;17: 605Y619
58. Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarasamy A. Association between thyroid autoantibodies and miscarriage and preterm birth: Meta-analysis of evidence. BMJ. 2011.;342:d2616
59. Glinoer D, Riahi M, Grün JP, Kinthaert J. Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J Clin Endocrinol Metab. 1994.;79:197Y204
60. Negro R. Thyroid autoimmunity and pre-term delivery: Brief review and meta-analysis. J Endocrinol Invest. 2011.; 34:155Y158
61. Roberts J, Jenkins C, Wilson R, et al. Recurrent miscarriage is associated with increased numbers of CD5/20 positive lymphocytes and an increased incidence of thyroid antibodies. Eur J Endocrinol. 1996.;134:84Y86
62. Bussen SS, Steck T Thyroie antibodies and their relation to antithrombin antibodies, anticardiolipin antibodies and lupus anticoagulant in women with recurrent spontaneous abortions (antithyroid, anticardiolipin and antithrombin autoantibodies and lupus anticoagulant in habitual aborters) Eur J Obstet Gynecol Reprod Biol 1997.;e4:139Y143
63. Kutteh WH, Yetman DL, Carr AC, Beck LA, Scott RT Jr Increaeed prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction FertileSteril1999.;e1: 843Y848
64. Iravani AT, Saeedi MM, Pakravesh J, Hamidi S, Abbasi M. Thyroid autoimmunity and recurrent spontaneous abortion in Iran: A case-control study. Endocr Pract. 2008.;14: 458Y464
65. Esplin MS, Branch DW, Silver R, Stagnaro-Green A. Thyroid autoantibodies are not associated with recurrent pregnancy loss. Am J Obstet Gynecol. 1998.;179:1583Y1586
66. Rushworth FH, Backos M, Rai R, Chilcott IT, Baxter N, Regan L. Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Hum Reprod. 2000.;15:1637Y1639
67. Yan J, Sripada S, Saravelos SH, Chen ZJ, Egner W, Li TC. Thyroid peroxidase antibody in women with unexplained recurrent miscarriage: Prevalence, prognostic value, and response to empirical thyroxine therapy. Fertil Steril. 2012.;98:378Y382
68. Baek KH, Lee EJ, Kim YS. Recurrent pregnancy loss: The key potential mechanisms. Trends Mol Med. 2007.;13: 310Y317
69. Muller AF, Verhoeff A, Mantel MJ, Berghout A. Thyroid autoimmunity and abortion: A prospective study in women undergoing in vitro fertilization. Fertil Steril. 1999.;71: 30Y34
70. Poppe K, Glinoer D, Tournaye H, et al. Assisted reproduction and thyroid autoimmunity: An unfortunate combination? J Clin Endocrinol Metab. 2003.;88:4149Y4152
71. Negro R, Mangieri T, Coppola L, et al. Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: A prospective study. Hum Reprod. 2005.;20:1529Y1533
72. Kilic S, Tasdemir N, Yilmaz N, Yuksel B, Gul A, Batioglu S. The effect of anti-thyroid antibodies on endometrial volume, embryo grade and IVF outcome. Gynecol Endocrinol. 2008.;24:649Y655
73. Toulis KA, Goulis DG, Venetis CA, et al. Risk of spontaneous miscarriage in euthyroid women with thyroid autoimmunity undergoing IVF: A meta-analysis. Eur J Endocrinol. 2010.;162:643Y652
74. Poppe K, Glinoer D, Tournaye H, et al. Impact of ovarian hyperstimulation on thyroid function in women with and without thyroid autoimmunity. J Clin Endocrinol Metab. 2004.;89:3808Y3812
75. Abdel Rahman AH, Aly Abbassy H, Abbassy AA. Improved in vitro fertilization outcomes after treatment of subclinical hypothyroidism in infertile women. Endocr Pract. 2010.;16:792Y797
76. Kim CH, Ahn JW, Kang SP, Kim SH, Chae HD, Kang BM. Effect of levothyroxine treatment on in vitro fertilization and pregnancy outcome in infertile women with subclinical hypothyroidism undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril. 2011.;95:1650Y1654
77. Velkeniers B, Van Meerhaeghe A, Poppe K, Unuane D, Tournaye H, Haentjens P. Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies: Systematic review and meta-analysis of RCTs. Hum Reprod Update. 2013.;19:251Y258
78. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: Effects on obstetrical complications. J Clin Endocrinol Metab. 2006.; 91:2587Y2591
79. Bath SC, Steer CD, Golding J, Emmett P, Rayman MP. Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: Results from the Avon Longitudinal Study of Parents and Children (ALSPAC). Lancet. 2013.;27:331Y337
80. Food and Nutrition Board. Institute of Medicine. Dietary Reference Intakes. Washington, DC: National Academy Press.; 2006:320Y327
81. Caldwel KL, Makhmudov A, Ely E, Jones RL, Wang RY. Iodine status of the US population, National Health and Nutrition Examination Survey, 2005Y2006 and 2007- 2008. Thyroid. 2011.;21:419Y427
82. Stagnaro-Green A, Sullivan S, Pearce EN. Iodine supplementation during pregnancy and lactation. JAMA. 2012.; 308:2463Y2464
83. Dosiou C, Barnes J, Schwartz A, Negro R, Crapo L, Stagnaro-Green A. Cost-effectiveness of universal and risk-based screening for autoimmune thyroid disease in pregnant women. J Clin Endocrinol Metab. 2012.;97: 1536Y1546.